Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Mankin

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
British Journal of Pharmacology|November 26, 2015
NVP-TAE684 reverses multidrug resistance (MDR) in human osteosarcoma by inhibiting P-glycoprotein (PGP1) functionShunan Ye, Jianming Zhang, Jacson Shen, et al.
Spine|May 13, 2010
Characterization and analysis of human chordoma cell linesCao Yang, Francis J Hornicek, Kirkham B Wood, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|February 7, 2014
Prognostic significance of miRNA-1 (miR-1) expression in patients with chordomaZhenfeng Duan, Jacson Shen, Xiaoqian Yang, et al.
Plos One|April 4, 2014
Synergistic effects of targeted PI3K signaling inhibition and chemotherapy in liposarcomaShang Guo, Hector Lopez-Marquez, Kenneth C Fan, et al.
Cancer Immunology Research|May 29, 2014
Programmed cell death ligand 1 expression in osteosarcomaJacson K Shen, Gregory M Cote, Edwin Choy, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 23, 2009
A validated disease severity scoring system for adults with type 1 Gaucher diseaseNeal J Weinreb, Maria D Cappellini, Timothy M Cox, et al.
Anticancer Research|June 17, 2009
Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordomaJoseph Schwab, Cristina Antonescu, Patrick Boland, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
British Journal of Pharmacology|November 26, 2015
NVP-TAE684 reverses multidrug resistance (MDR) in human osteosarcoma by inhibiting P-glycoprotein (PGP1) functionShunan Ye, Jianming Zhang, Jacson Shen, et al.
Spine|May 13, 2010
Characterization and analysis of human chordoma cell linesCao Yang, Francis J Hornicek, Kirkham B Wood, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|February 7, 2014
Prognostic significance of miRNA-1 (miR-1) expression in patients with chordomaZhenfeng Duan, Jacson Shen, Xiaoqian Yang, et al.
Plos One|April 4, 2014
Synergistic effects of targeted PI3K signaling inhibition and chemotherapy in liposarcomaShang Guo, Hector Lopez-Marquez, Kenneth C Fan, et al.
Cancer Immunology Research|May 29, 2014
Programmed cell death ligand 1 expression in osteosarcomaJacson K Shen, Gregory M Cote, Edwin Choy, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 23, 2009
A validated disease severity scoring system for adults with type 1 Gaucher diseaseNeal J Weinreb, Maria D Cappellini, Timothy M Cox, et al.
Anticancer Research|June 17, 2009
Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordomaJoseph Schwab, Cristina Antonescu, Patrick Boland, et al.
Pageof 6